UM Zanger, M Schwab - Pharmacology & therapeutics, 2013 - Elsevier
Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and response. Of 57 putatively functional human CYPs only about a dozen enzymes, belonging …
Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions, including gastroesophageal reflux disease, gastric and …
JK Hicks, K Sangkuhl, JJ Swen… - Clinical …, 2017 - ncbi.nlm.nih.gov
Abstract CYP2D6 and CYP2C19 polymorphisms affect the exposure, efficacy and safety of tricyclic antidepressants (TCAs), with some drugs being affected by CYP2D6 only (eg …
Genetic polymorphisms in cytochrome P450 (CYP) genes can result in altered metabolic activity toward a plethora of clinically important medications. Thus, single nucleotide variants …
B Moriyama, AO Obeng, J Barbarino… - Clinical …, 2017 - Wiley Online Library
Voriconazole, a triazole antifungal agent, demonstrates wide interpatient variability in serum concentrations, due in part to variant CYP2C19 alleles. Individuals who are CYP2C19 …
SA Scott, K Sangkuhl, CM Stein… - Clinical …, 2013 - Wiley Online Library
Cytochrome P450 (CYP) 2C19 catalyzes the bioactivation of the antiplatelet prodrug clopidogrel, and CYP2C19 loss‐of‐function alleles impair formation of active metabolites …
Y Wang, X Zhao, J Lin, H Li, SC Johnston, Y Lin, Y Pan… - Jama, 2016 - jamanetwork.com
Importance Data are limited regarding the association betweenCYP2C19genetic variants and clinical outcomes of patients with minor stroke or transient ischemic attack treated with …
N El Rouby, JJ Lima, JA Johnson - Expert opinion on drug …, 2018 - Taylor & Francis
ABSTRACT Introduction: Proton Pump inhibitors (PPIs) are commonly used for a variety of acid related disorders. Despite the overall effectiveness and safety profile of PPIs, some …